Terms: = Colorectal cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Diagnosis
32 results:
1. Prognostic and tumor immunity implication of inflammatory bowel disease-associated genes in colorectal cancer.
Wang D; Xie B
Eur J Med Res; 2022 Jun; 27(1):91. PubMed ID: 35698180
[TBL] [Abstract] [Full Text] [Related]
2. The role of cell surface proteins gene expression in diagnosis, prognosis, and drug resistance of colorectal cancer: In silico analysis and validation.
Nazempour N; Taleqani MH; Taheri N; Haji Ali Asgary Najafabadi AH; Shokrollahi A; Zamani A; Fattahi Dolatabadi N; Peymani M; Mahdevar M
Exp Mol Pathol; 2021 Dec; 123():104688. PubMed ID: 34592197
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic values of MMP-7, MMP-9, MMP-11, timp-1, timp-2, CEA, and CA19-9 in patients with colorectal cancer.
Huang X; Lan Y; Li E; Li J; Deng Q; Deng X
J Int Med Res; 2021 May; 49(5):3000605211012570. PubMed ID: 33942633
[TBL] [Abstract] [Full Text] [Related]
4. Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic cancer Early Detection.
Fahrmann JF; Schmidt CM; Mao X; Irajizad E; Loftus M; Zhang J; Patel N; Vykoukal J; Dennison JB; Long JP; Do KA; Zhang J; Chabot JA; Kluger MD; Kastrinos F; Brais L; Babic A; Jajoo K; Lee LS; Clancy TE; Ng K; Bullock A; Genkinger J; Yip-Schneider MT; Maitra A; Wolpin BM; Hanash S
Gastroenterology; 2021 Mar; 160(4):1373-1383.e6. PubMed ID: 33333055
[TBL] [Abstract] [Full Text] [Related]
5. Bioinformatic Identification of Hub Genes and Analysis of Prognostic Values in colorectal cancer.
Lei X; Jing J; Zhang M; Guan B; Dong Z; Wang C
Nutr Cancer; 2021; 73(11-12):2568-2578. PubMed ID: 33153324
[TBL] [Abstract] [Full Text] [Related]
6. Identification and verification of three key genes associated with survival and prognosis of COAD patients via integrated bioinformatics analysis.
Liu Y; Li C; Dong L; Chen X; Fan R
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32936304
[TBL] [Abstract] [Full Text] [Related]
7.
Zhou J; Xie Z; Cui P; Su Q; Zhang Y; Luo L; Li Z; Ye L; Liang H; Huang J
Biomed Res Int; 2020; 2020():1204605. PubMed ID: 32566650
[TBL] [Abstract] [Full Text] [Related]
8. A Meta-Analysis of Proteomic Blood Markers of colorectal cancer.
Chen X; Sun J; Wang X; Yuan Y; Cai L; Xie Y; Fan Z; Liu K; Jiao X
Curr Med Chem; 2021; 28(6):1176-1196. PubMed ID: 32338203
[TBL] [Abstract] [Full Text] [Related]
9. Nutritional prevention of colorectal cancer.
Hull MA
Proc Nutr Soc; 2021 Feb; 80(1):59-64. PubMed ID: 32019626
[TBL] [Abstract] [Full Text] [Related]
10. Agrin in the Muscularis Mucosa Serves as a Biomarker Distinguishing Hyperplastic Polyps from Sessile Serrated Lesions.
Rickelt S; Condon C; Mana M; Whittaker C; Pfirschke C; Roper J; Patil DT; Brown I; Mattia AR; Zukerberg L; Zhao Q; Chetty R; Lauwers GY; Neyaz A; Leijssen LGJ; Boylan K; Yilmaz OH; Deshpande V; Hynes RO
Clin Cancer Res; 2020 Mar; 26(6):1277-1287. PubMed ID: 31852835
[TBL] [Abstract] [Full Text] [Related]
11. timp1 mRNA in tumor-educated platelets is diagnostic biomarker for colorectal cancer.
Yang L; Jiang Q; Li DZ; Zhou X; Yu DS; Zhong J
Aging (Albany NY); 2019 Oct; 11(20):8998-9012. PubMed ID: 31639773
[TBL] [Abstract] [Full Text] [Related]
12. The identification of a common different gene expression signature in patients with colorectal cancer.
Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
[TBL] [Abstract] [Full Text] [Related]
13. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract] [Full Text] [Related]
14. Increased serological, cancer-associated protein biomarker levels at diagnosis of large bowel adenoma: Risk of subsequent primary malignancy?
Piper TB; Jørgensen LN; Olsen J; Nielsen KT; Davis G; Johansen JS; Jarle Christensen I; Nielsen HJ
Acta Oncol; 2019; 58(sup1):S42-S48. PubMed ID: 30523734
[TBL] [Abstract] [Full Text] [Related]
15. timp-1 is a novel serum biomarker for the diagnosis of colorectal cancer: A meta-analysis.
Meng C; Yin X; Liu J; Tang K; Tang H; Liao J
PLoS One; 2018; 13(11):e0207039. PubMed ID: 30458003
[TBL] [Abstract] [Full Text] [Related]
16. Profile of Expression of Genes Encoding Matrix Metallopeptidase 9 (MMP9), Matrix Metallopeptidase 28 (MMP28) and timp Metallopeptidase Inhibitor 1 (timp1) in colorectal cancer: Assessment of the Role in diagnosis and Prognostication.
Lorenc Z; Waniczek D; Lorenc-Podgórska K; Krawczyk W; Domagała M; Majewski M; Mazurek U
Med Sci Monit; 2017 Mar; 23():1305-1311. PubMed ID: 28293015
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic significance of timp-1 level in serum and its immunohistochemical expression in colorectal cancer patients.
Niewiarowska K; Pryczynicz A; Dymicka-Piekarska V; Gryko M; Cepowicz D; Famulski W; Kemona A; Guzińska-Ustymowicz K
Pol J Pathol; 2014 Dec; 65(4):296-304. PubMed ID: 25693084
[TBL] [Abstract] [Full Text] [Related]
18. Characteristics of fatty acid distribution is associated with colorectal cancer prognosis.
Zhang J; Zhang L; Ye X; Chen L; Zhang L; Gao Y; Kang JX; Cai C
Prostaglandins Leukot Essent Fatty Acids; 2013 May; 88(5):355-60. PubMed ID: 23465412
[TBL] [Abstract] [Full Text] [Related]
19. Plasma timp1 level is a prognostic factor in patients with liver metastases.
Bunatova K; Pesta M; Kulda V; Topolcan O; Vrzalova J; Sutnar A; Treska V; Pecen L; Liska V
Anticancer Res; 2012 Oct; 32(10):4601-6. PubMed ID: 23060593
[TBL] [Abstract] [Full Text] [Related]
20. Saliva and plasma timp-1 in patients with colorectal cancer: a prospective study.
Holten-Andersen L; Christensen IJ; Jensen SB; Reibel J; Laurberg S; Nauntofte B; Brünner N; Nielsen HJ
Scand J Gastroenterol; 2012 Oct; 47(10):1234-41. PubMed ID: 22871105
[TBL] [Abstract] [Full Text] [Related]
[Next]
